Business Wire

ADTRAN

20.6.2024 14:01:32 CEST | Business Wire | Press release

Share
Adtran joins LU-CIX community as a Gold Member

Adtran and the Luxembourg Internet eXchange (LU-CIX), today announced that Adtran has joined the LU-CIX community as a Gold Member. This addition expands and enhances LU-CIX’s supporting member ecosystem, which is key for the digital infrastructure of Luxembourg and beyond. Adtran joining the community cements a longstanding relationship with LU-CIX. Its FSP 3000 open optical transport solution was instrumental in expanding LU-CIX’s network capacity efficiently and sustainably, and the Adtran ALM fiber monitoring platform is helping boost the reliability of LU-CIX’s services.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240620733461/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Adtran’s technology is helping LU-CIX advance Luxembourg’s digital infrastructure. (Photo: Business Wire)

“We’re thrilled to have Adtran join us as a Gold Member. The dedication to openness and collaborative innovation that the Adtran team brings will help lift our collective efforts. Our history of success together sets a solid foundation for this partnership. Moreover, Adtran’s compact, energy-efficient technology perfectly aligns with our sustainability goals and enhances the performance and reliability of our network,” said Claude Demuth, chairman of LU-CIX. “This partnership underscores the importance of robust relationships in propelling our digital infrastructure forward and reinforcing Luxembourg’s status as a premier digital hub in Europe.”

LU-CIX is a major European internet exchange, optimizing connectivity and internet speed by facilitating direct traffic routing among connected networks. Through its neutral and highly reliable platform, it supports the digital economy and boosts data transmission security across the country and beyond. The LU-CIX community, comprising internet service providers, telecommunication companies and content networks, collaborates to improve network efficiency and strengthen Luxembourg as a major digital hub. By welcoming Adtran, LU-CIX is broadening its technological capabilities. Adtran’s solutions enhance network performance, flexibility and reliability, delivering major benefits across Europe’s digital landscape. What’s more, Adva Network Security provides network security solutions approved by the Bundesamt für Sicherheit in der Informationstechnik (BSI) that comprehensively protect networks built on Adtran FSP 3000 transport technology, providing its customers with access to quantum-resistant communication and fortifying digital infrastructure against future threats.

“We’re very pleased to be part of the LU-CIX community. The power of collaborative initiatives like this one cannot be overstated. The LU-CIX supporting member hub is key to driving technological advancements and shaping the future of digital infrastructure in this region and across Europe,” commented Stuart Broome, GM of EMEA sales at Adtran. “LU-CIX’s proactive approach to interworking and its leadership in the industry align perfectly with our commitment to open, multi-vendor networks. Our technologies are ideal for enhancing and supporting the scalability and security of major internet exchanges like LU-CIX, ensuring a more connected and resilient future.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

About LU-CIX

LU-CIX ASBL, the LUxembourg Internet eXchange, was founded in 2009 based on a not-for-profit membership association with an open and neutral philosophy. It aims to develop and support the Internet and data center ecosystem in Luxembourg by providing the national peering infrastructure and by promoting the national ICT community. LU-CIX brings a major contribution to the Luxembourg Internet community by organising its leading industry event, the Luxembourg Internet Days, which takes place every year and attracts over a thousand industry experts and decision makers from all around the globe. LU-CIX, together with the Chamber of Commerce of Luxembourg and the Ministry for Digitalisation, has launched the instant messaging solution Luxchat for the whole population and enterprises in Luxembourg. This solution, free for users, without advertising and without use of personal data, does respect the privacy of its users. LU-CIX also runs the datacenters-in-europe.com platform, which gathers the Luxembourg data center and Internet related players to promote Luxembourg as the best place for a data center and ICT business in the heart of Europe. LU-CIX GIE was also launched in 2009 to operate the Internet eXchange infrastructure. In 2021, the Luxembourgish State, together with LU-CIX GIE, launched MyConnectivity G.I.E. to support the access to high performance connectivity for all (private households and businesses) in the context of the 5G and ultra-high-speed national strategies. More information at lu-cix.lu.

Published by 
ADTRAN Holdings, Inc. 
www.adtran.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240620733461/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye